New radiation approach aims to control tough pancreatic cancer
NCT ID NCT03505229
First seen Jan 31, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This study tests a high-dose, precise radiation treatment called SBRT for people with high-risk localized pancreatic cancer. The goal is to see if it can stop the cancer from growing in the treated area for at least 12 months. About 30 participants will receive SBRT along with chemotherapy, and researchers will monitor side effects and how well the cancer responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK LOCALISED PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Royal North Shore Hospital
St Leonards, New South Wales, 2065, Australia
Conditions
Explore the condition pages connected to this study.